Ramesh Neelamegam Selected Research

Fragile X Syndrome (Martin Bell Syndrome)

1/2021

In vivo imaging of mGlu5 receptor expression in humans with Fragile X Syndrome towards development of a potential biomarker.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Ramesh Neelamegam Research Topics

Disease

3	Neoplasms (Cancer) 10/2022 - 01/2013
2	Tauopathies 01/2024 - 11/2019
2	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2024 - 11/2019
2	Cerebral Amyloid Angiopathy (Congophilic Angiopathy) 01/2024 - 11/2019
2	Hemorrhage 01/2024 - 11/2019
2	Demyelinating Diseases (Demyelinating Disease) 01/2021 - 01/2021
1	Mental Disorders (Mental Disorder) 01/2023
1	Fragile X Syndrome (Martin Bell Syndrome) 01/2021
1	Brain Injuries (Brain Injury) 01/2021
1	Flushing 05/2020
1	Chronic Traumatic Encephalopathy 11/2019
1	Frontotemporal Lobar Degeneration (Degeneration, Frontotemporal Lobar) 11/2019
1	Progressive Supranuclear Palsy (Steele Richardson Olszewski Syndrome) 11/2019
1	Alzheimer Disease (Alzheimer's Disease) 11/2019
1	Pick Disease of the Brain (Pick's Disease) 11/2019
1	Corticobasal Degeneration 11/2019
1	Dementia (Dementias) 11/2019
1	Pain (Aches) 01/2019
1	Lymphangioleiomyomatosis (Lymphangiomyomatosis) 12/2018
1	Tuberous Sclerosis (Bourneville's Disease) 12/2018
1	Obesity 02/2013
1	Schizophrenia (Dementia Praecox) 02/2013
1	Heart Diseases (Heart Disease) 01/2013
1	Cutaneous T-Cell Lymphoma (Lymphoma, T Cell, Cutaneous) 01/2013
1	Brain Neoplasms (Brain Tumor) 12/2012
1	Brain Diseases (Brain Disorder) 02/2012

Drug/Important Bio-Agent (IBA)

2	neuromelaninIBA 01/2024 - 11/2019
2	DNA-Binding Proteins (DNA Binding Protein)IBA 01/2024 - 11/2019
2	Melanins (Melanin)IBA 01/2024 - 11/2019
2	Biomarkers (Surrogate Marker)IBA 01/2021 - 12/2018
1	SynucleinsIBA 01/2024
1	7- (6- fluoropyridin- 3- yl)- 5H- pyrido(4,3- b)indoleIBA 01/2024
1	Amyloid (Amyloid Fibrils)IBA 01/2024
1	metabotropic glutamate receptor 2IBA 01/2023
1	TubulinIBA 10/2022
1	Thymidine KinaseIBA 10/2022
1	LigandsIBA 10/2022
1	Cytotoxins (Cytolysins)IBA 10/2022
1	Potassium Channels (Potassium Channel)IBA 01/2021
1	Carbon-11IBA 01/2021
1	AmmoniaIBA 05/2020
1	BuffersIBA 05/2020
1	SaltsIBA 05/2020
1	MK-6240IBA 11/2019
1	kappa Opioid Receptors (kappa Opioid Receptor)IBA 01/2019
1	Sirolimus (Rapamycin)FDA Link 12/2018
1	trans-sodium crocetinate (crocetin)IBA 12/2018
1	MTOR InhibitorsIBA 12/2018
1	lipoarabinomannan (LAM)IBA 12/2018
1	Serotonin (5 Hydroxytryptamine)IBA 02/2013
1	5-HT2C Serotonin ReceptorIBA 02/2013
1	Vorinostat FDA Link 01/2013
1	Histone Deacetylase InhibitorsIBA 01/2013
1	Hydroxamic Acids (Hydroxamic Acid)IBA 01/2013
1	ProdrugsIBA 12/2012
1	Temozolomide (Temodar)FDA LinkGeneric 12/2012
1	Alkylating AgentsIBA 12/2012

Therapy/Procedure

4	Therapeutics 01/2021 - 02/2012
1	Operative Surgical Procedures 01/2021